Leveraging Northway Biotech’s 20+ years of CDMO expertise, Kaida BioPharma is advancing KAD101, a targeted therapy for ...

Finance Income, net was $1.0 million for the three months ended March 31, 2025, compared to $0.7 million in the same period ...

The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its ...

The project involves the design and construction of three tunnels spanning an estimated 13.8km, along with other features.

Viking Therapeutics offers leaner operations, lower complexity, faster trial execution, and less execution risk. Learn more ...

"We are proud to partner with Kaida BioPharma on the development of KAD101,” said Prof. Vladas Algirdas Bumelis, CEO and ...

Scientific advancements in medicine, agriculture and environmental science play a crucial role in offering solutions to ...

Supreme Court upholds lower court's decision that SK bioscience's PCV13 components do not fall within scope of Pfizer's patent claims - Anadolu Ajansı ...

CRISPR-edited iPSCs uncover early mitochondrial defects shared across ALS mutations, revealing pathways that could guide future treatments.

Please enter your username and password below, if you are not yet a member of BioTechniques remember you can register for ...

Regeneron Pharmaceuticals enters into asset purchase agreement to acquire 23andMe for $256 million: Tarrytown, New York Wednesday, May 21, 2025, 13:00 Hrs [IST] Regeneron Pharmace ...

Roughly five months after AstraZeneca scrapped a major investment plan in its home country, the United Kingdom has found a ...